Kestra Advisory Services’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-510
Closed -$4.62K 2676
2024
Q1
$4.62K Hold
510
﹤0.01% 2444
2023
Q4
$5.62K Hold
510
﹤0.01% 2262
2023
Q3
$9.04K Sell
510
-14
-3% -$510 ﹤0.01% 2099
2023
Q2
$28.8K Sell
524
-24
-4% -$1.53K ﹤0.01% 2066
2023
Q1
$37.3K Buy
548
+13
+2% +$1.01K ﹤0.01% 2003
2022
Q4
$32.4K Buy
535
+25
+5% +$2.32K ﹤0.01% 2205
2022
Q3
$51K Buy
+510
New +$59.4K ﹤0.01% 2030

Other funds holding RBOT

Kestra Advisory Services's RBOT Position: Q2 2024 in Review

Kestra Advisory Services sold out of Vicarious Surgical (RBOT) in Q2 2024, closing a stake of 510 shares — an estimated $4.62K sold.

Kestra Advisory Services first reported a position in RBOT in Q3 2022 and held it in 7 quarters. The position peaked at $51K in Q3 2022. 38 funds tracked by Wall St. Rank hold RBOT as of Q2 2024.

  • Kestra Advisory Services reported no remaining Vicarious Surgical position as of Q2 2024 after selling out during the quarter.
  • Kestra Advisory Services sold 510 Vicarious Surgical shares in Q2 2024, an estimated $4.62K.
  • Kestra Advisory Services first reported a position in Vicarious Surgical in Q3 2022 and held it in 7 quarters.
  • Kestra Advisory Services's Vicarious Surgical position peaked at $51K in Q3 2022.
  • 38 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2024.

Based on Kestra Advisory Services's 13F filing for Q2 2024, filed 14 Aug 2024.